The Baystreet article that BooDog posted #52509 is a MUST
The Baystreet article that BooDog posted #52509 is a MUST read. Here are some great points from the article.
===========================================================================
“There are many more similarities between these two companies that portend success and lend support to the notion that IPIX is arguably undervalued.”
“Galera and IPIX are certainly looking in the right direction in targeting head and neck cancer patients receiving chemoradiation, a treatment regimen where the incidence of SOM is stunningly high at over 70 percent. Moreover, there are no FDA-approved therapies for treating SOM in solid tumors, creating a pervasive area of high unmet medical need and a market estimated in excess of $2 billion.”
“In the case of GC4419 (Galera) for SOM, the drug is delivered intravenously.”
“oral drugs are the preferred method of administration for patients compared to laying there while the drug slowly drips through an IV. To that point, an oral drug is far more convenient, with administration available in an array of settings compared to IV. It also less expensive, likely making it the preferred method of not only insurance companies, but also doctors writing the prescriptions.”
"In the IPIX trial, treatment with Brilacidin in the modified Intent-to-Treat (mITT) population reduced the relative incidence of SOM by 65.0% compared to placebo. In the Per Protocol population, the relative incidence of SOM decreased by 80.3% compared to placebo. It bears repeating that, while the sample size was small for this group, treatment with Brilacidin oral rinse lowered the rate of SOM by over 80%."
“Innovation Pharma needs to find this quality of financial partners, but the lack of them at this point by no means justifies its paltry market capitalization of $18 million.
“For publicly-listed IPIX, whatever weight has been holding the stock down may finally be lifted so that the company can achieve a fair valuation alongside its money-raising peer so that the stock can rise from its current depressed level.”
8
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Switchgear Monitoring: A Crucial Component in Modern Power Grids When the chips are down, it's the grid that keeps the lights on. Now, looks like switchgear monitoring systems are riding high on this global necessity. Fueled by infrastructure upgrades, the market's slated to leap from $2.36 billion in 2026 to a whopping $3.80 billion by 2031, clocking a solid 10.1% CAGR....
Continue Reading
Understanding Alfa Laval's Third Quarter Surge Alfa Laval's third quarter report isn't just another financial document; it's a reflection of the volatility and unpredictable nature of the engineering sector. Sure, revenues and earnings have shot up, but there's a hint of caution as we steer into the fourth quarter. Order intake—a term that gives every investor a reason...
Continue Reading
Study Points to Ambient AI's Promise in Oncology Some days, the world of cancer care is a real beast to tackle. But today, we've got a glimpse into how technology, and specifically ambient AI, might just help slay some of the burdens that these healthcare warriors face daily. The Florida Cancer Specialists & Research Institute (FCS) joined hands to dive into how this tech...
Continue Reading
Pizza with a Punch: Irvine's Tifosi Heats Up We've got another chef-driven concept cooking up in Irvine. This time, it's Tifosi Pizza + Trattoria stirring the pot at Centerview. The spot's bringing 'New, New York' style pizza, blending Big Apple boldness with Italian tradition, and tossing in a bit of California flair for good measure. "The main idea is to create...
Continue Reading
Honeywell's Bumpy Ride Rattles Investors Something's brewing over at Honeywell Aerospace, Inc. (NASDAQ:HONA) and it's not your regular cup of joe. Investors, brace yourselves, because a securities fraud class action lawsuit is stacking up against them. With shares plummeting 23.16% in a whirlwind of a market day, it's kind of hard not to get a little riled up, isn't it?...
Continue Reading
Concrete: The Unsung Hero of Your Pool's Success You know, everyone always raves about that sparkling pool, but let's be real—it's the concrete holding the whole gig together. James White from White's Pools in Loganville, GA, drops some knowledge in a recent HelloNation piece about the unsung hero of backyard oases: custom concrete. Yeah, it's not sexy, but when you're...
Continue Reading
Getting Set for a Big Move Blue Moon Metals Inc. isn't sitting around with its thumbs in its pockets. The company has made some strides with their Springer Tungsten Mine project in Imlay, Nevada. Let's break down what these folks are up to. Refurbished Up for the Fast Track The rock mover here is the refurbishment of the Springer processing plant. You don't just snap your...
Continue Reading
The High Stakes for Fluence Energy Investors Well, here's a plot twist, or perhaps not for those who've been keeping an eye on the renewable energy sector. Fluence Energy (NASDAQ:FLNC), a supposed heavyweight in energy storage and renewable innovations, is tangled in a legal web over securities fraud. As of now, Fluence has been slapped with a class action lawsuit...
Continue Reading
A Heavyweight Joiner Shakes Up Amgen's Ranks You can almost feel the ground shake when Amgen, a tech giant in biotech, ropes in a high-profile namesake from outside its usual league. David W. Gibbs, the former CEO of Yum! Brands, is now staking his claim at Amgen as a member of its Board of Directors. Effective immediately, Gibbs isn’t just a filler; he's diving...
Continue Reading
EQS Group's Bold Climate Commitments The news hits like a gust of clean air — EQS Group's climate targets are now stamped with the seal of approval from the Science Based Targets initiative (SBTi). This isn't just your typical corporate green pledge: we're talking serious, validated commitments pushing for net-zero emissions by 2050. Decoding EQS Group's Impactful...
Continue Reading
ction End -->
Top 5 Most Recently Viewed Articles
AI Innovations Driving Digital Transformation in Oil & Gas The oil and gas industry is experiencing significant growth fueled by digital transformation. Investments and partnerships have become pivotal, driving a market estimated to increase by USD 56.4 billion from 2025 to 2029. This transformation is underpinned by advancements in technology, particularly artificial...
Continue Reading
Fintech's New Era of Growth and Innovation Recent insights reveal that the fintech industry is experiencing remarkable growth and transformative changes. This revival is highlighted in a report from knowledgeable industry analysts who indicate that this sector is on the brink of substantial disruption through innovative technologies and calculated expansion strategies,...
Continue Reading
Greystone Logistics Announces Stock Buybacks In a significant move to strengthen its financial foundation, Greystone Logistics, Inc. (OTCQB: GLGI), known for its innovative approach to sustainable manufacturing, has successfully completed the redemption of $5 million Preferred Stock. Additionally, the company has repurchased an impressive 620,052 shares of its common...
Continue Reading
Important Actions for Caribou Biosciences Investors In the dynamic landscape of securities litigation, investors of Caribou Biosciences, Inc. (NASDAQ: CRBU) are facing a critical deadline. With the date of lead plaintiff designation approaching, it is essential for affected individuals to understand their rights and the necessary steps they can take to protect their...
Continue Reading
Mattr Welcomes Jane Skoblo as New Director Mattr Corp. (TSX: MATR) is excited to announce the addition of Jane Skoblo to its Board of Directors. This move is part of a strategic transitional plan as the company prepares for upcoming changes in leadership. Skoblo, who officially stepped into her role on August 13, 2025, will take an active part in the Audit and...
Continue Reading
